Topic Menu
► Topic MenuTopic Editors

2. Frailty and Cognitive Impairment—FROG Research Group, University of Valencia, 46010 Valencia, Spain

2. Frailty Research Organized Group (FROG), University of Valencia, 46010 Valencia, Spain

2. Frailty Research Organized Group (FROG), University of Valencia, 46010 Valencia, Spain
Mechanisms and Treatments of Neurodegenerative Diseases
Topic Information
Dear Colleagues,
Neurodegenerative diseases encompass a number of disorders that primarily affect neurons in the human nervous system. Neurons are the building blocks of the nervous system. Normally, neurons do not reproduce or replace themselves, so the body cannot replace them with other neurons when they are damaged.
Neurodegenerative diseases are incurable and debilitating, resulting in the progressive degeneration and/or death of neurons. This causes several deficits that impair quality of life and increase the odds of morbidity and premature mortality in affected individuals. Both pharmacological and nonpharmacological interventions can delay the progression of such diseases and, in some cases, the treatment of comorbid conditions can improve the quality of life of the individuals with neurodegenerative diseases.
This Topic wishes to shed new light on this exciting and insightful field of research from a multidisciplinary perspective. This Topic, “Mechanisms and Treatments of Neurodegenerative Diseases” will reflect the intense interplay between neurology and neuroscience as well as with other health sciences at the leading edge of this growing research field, which has led to suggestions of new opportunities for improving the diagnosis, treatment, and care of patients with neurodegenerative diseases, or to prevent adverse outcomes. In this Topic, the readership will find accounts of relevant research carried out by numerous healthcare professionals and researchers with extensive knowledge on basic and clinical settings, and the intention is to address new topics of interest of specific importance within the spectrum of basic research to clinical practice.
Prof. Dr. Omar Cauli
Dr. Pilar Pérez-Ros
Dr. Vanessa Ibáñez del Valle
Topic Editors
Article processing charge will be waived for all accepted manuscripts in Physiologia from 1 May to 31 December 2021.
Keywords
- Alzheimer’s disease
- Parkinson’s disease
- dementia
- autoimmune disorders
- biomarkers
- gender differences
- cellular pathology
- treatment
- palliative care
- comorbidity
- risk and prognostic factors
- chronic conditions
- caregiver
- health education
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
![]()
Life
|
3.2 | 4.3 | 2011 | 17.8 Days | CHF 2600 |
![]()
Diseases
|
2.9 | 0.8 | 2013 | 21.4 Days | CHF 1800 |
![]()
Physiologia
|
- | - | 2021 | 19.6 Days | CHF 1000 |
![]()
Brain Sciences
|
2.7 | 4.8 | 2011 | 15.6 Days | CHF 2200 |
![]()
Medicina
|
2.4 | 3.3 | 1920 | 17.1 Days | CHF 2200 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.